CLINICAL-EVALUATION OF CALCIUM-ANTAGONIST DRUGS

被引：2
|
作者：
GHIO, S
SPECCHIA, G
机构：
[1] POLICLIN SAN MATTEO,IRCCS,DIV CARDIOL,I-27100 PAVIA,ITALY
[2] UNIV PAVIA,DIPARTIMENTO MED INTERNE,SEZ CARDIOL,I-27100 PAVIA,ITALY
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1992年 / 20卷
关键词：
CALCIUM ANTAGONISTS; CORONARY ARTERY DISEASE; CLINICAL TRIALS;
D O I：
10.1097/00005344-199200207-00013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Calcium-antagonist drugs are therapeutic agents of first choice in patients with coronary artery disease. We have reviewed a number of clinical trials in which the safety and efficacy of calcium blockers have been tested and discuss the established clinical effects of these compounds, which range from relief of angina and improved quality of life (both in patients with ischemia due to reduction in coronary flow and in patients with ischemia due to increased O2 demand) to a favorable effect on the course of coronary atherosclerosis and, finally, (at least for some of these agents) to an improvement in prognosis.
引用
收藏
页码：S71 / S74
页数：4
相关论文
共 50 条
12345